Pneumologie : ce qui a changé en 2022 [Pneumology: what's new in 2022]

Details

Ressource 1Download: file (1).pdf (1085.10 [Ko])
State: Public
Version: Final published version
License: CC BY-NC-ND 4.0
Serval ID
serval:BIB_7306A7EE3572
Type
Article: article from journal or magazin.
Publication sub-type
Review (review): journal as complete as possible of one specific subject, written based on exhaustive analyses from published work.
Collection
Publications
Institution
Title
Pneumologie : ce qui a changé en 2022 [Pneumology: what's new in 2022]
Journal
Revue medicale suisse
Author(s)
Kolb M., Lechartier B., Aubert J.D., Daccord C.
ISSN
1660-9379 (Print)
ISSN-L
1660-9379
Publication state
Published
Issued date
18/01/2023
Peer-reviewed
Oui
Volume
19
Number
809-10
Pages
77-81
Language
french
Notes
Publication types: English Abstract ; Journal Article
Publication Status: ppublish
Abstract
This selection of pneumological novelties of the year 2022 is not limited to pharmacological acquisitions but also includes progress in diagnostic strategies and the global management of respiratory diseases. We have chosen three pneumological issues. As cannabis is the most consumed illegal substance in Switzerland, it is important to know its impact on pulmonary physiology. An update of the international guidelines on pulmonary fibrosis as well as the European guidelines on pulmonary hypertension provides practical answers to the many clinical problems encountered in the management of these diseases. The key messages from these two consensus documents are reported here.
Keywords
Humans, Pulmonary Medicine, Hypertension, Pulmonary/diagnosis, Respiratory Tract Diseases, Switzerland, Pulmonary Fibrosis
Pubmed
Create date
31/01/2023 17:37
Last modification date
22/07/2023 6:58
Usage data